GQG Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

GQG Partners’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,008,759	Closed	-$31.7M	–	102
2024 Q4	$31.7M	Sell	2,008,759 -175,996	-8%	-$2.64M	0.05%	57
2024 Q3	$34.7M	Hold	2,184,755	–	–	0.05%	56
2024 Q2	$33.3M	Hold	2,184,755	–	–	0.05%	42
2024 Q1	$32.1M	Hold	2,184,755	–	–	0.05%	42
2023 Q4	$30.4M	Sell	2,184,755 -1,427,485	-40%	-$19.1M	0.06%	44
2023 Q3	$48.3M	Hold	3,612,240	–	–	0.11%	40
2023 Q2	$45.6M	Buy	3,612,240 +835,625	+30%	+$9.75M	0.1%	37
2023 Q1	$31.6M	Buy	2,776,615 +1,890,055	+213%	+$20.4M	0.08%	46
2022 Q4	$9.18M	Hold	886,560	–	–	0.02%	57
2022 Q3	$9.28M	Hold	886,560	–	–	0.03%	54
2022 Q2	$9.82M	Buy	+886,560	New	+$9.64M	0.02%	52

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GQG Partners's RDY Position: Q1 2025 in Review

GQG Partners sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 2,008,759 shares — an estimated $31.7M sold.

GQG Partners first reported a position in RDY in Q2 2022 and held it in 11 quarters. The position peaked at $48.3M in Q3 2023. 245 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

GQG Partners reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
GQG Partners sold 2,008,759 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $31.7M.
GQG Partners first reported a position in Dr. Reddy's Laboratories in Q2 2022 and held it in 11 quarters.
GQG Partners's Dr. Reddy's Laboratories position peaked at $48.3M in Q3 2023.
245 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on GQG Partners's 13F filing for Q1 2025, filed 13 May 2025.